UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000040540 |
|---|---|
| Receipt number | R000046275 |
| Scientific Title | Longitudinal MRI study on acquisition of novel categories |
| Date of disclosure of the study information | 2020/05/27 |
| Last modified on | 2023/05/31 10:36:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Category Acquisition MRI study
Acronym
Category Acquisition
Scientific Title
Longitudinal MRI study on acquisition of novel categories
Scientific Title:Acronym
Category Acquisition
Region
| Japan |
Condition
Condition
Adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We aim to uncover longitudinal changes of neural systems underlying novel visual category acquisition
Basic objectives2
Others
Basic objectives -Others
Observation study
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Relationship among task fMRI, structural MRI, diffusion MRI, quantitative MRI, MRS, and behavioral scores (visual cognition, learning, and memory)
Key secondary outcomes
Relationship between personality and MRI signals
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
YES
Dynamic allocation
NO
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Behavior,custom |
Interventions/Control_1
Learning a foreign language
Interventions/Control_2
Learning a foreign language
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 40 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Their mother language should be Japanese.
Key exclusion criteria
Psychiatric disorders including drug dependence
Serious medical illness
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Makiko |
| Middle name | |
| Last name | Yamada |
Organization
National Institutes for Quantum Science and Technology
Division name
Institute of Quantum Medical Science
Zip code
263-8555
Address
4-9-1 Anagawa, Inage, Chiba
TEL
043-206-3249
yamada.makiko@qst.go.jp
Public contact
Name of contact person
| 1st name | Daisuke |
| Middle name | |
| Last name | Matsuyoshi |
Organization
National Institutes for Quantum Science and Technology
Division name
Institute of Quantum Medical Science
Zip code
263-8555
Address
4-9-1 Anagawa, Inage, Chiba
TEL
043-206-3249
Homepage URL
matsuyoshi.daisuke@qst.go.jp
Sponsor or person
Institute
National Institutes for Quantum Science and Technology
Institute
Department
Personal name
Funding Source
Organization
JSPS/MEXT
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board at QST
Address
4-9-1 Anagawa, Inage, Chiba
Tel
043-206-4709
helsinki@qst.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立研究開発法人量子科学技術研究開発機構（千葉県）
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 05 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2020 | Year | 04 | Month | 03 | Day |
Date of IRB
| 2020 | Year | 04 | Month | 03 | Day |
Anticipated trial start date
| 2023 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 05 | Month | 27 | Day |
Last modified on
| 2023 | Year | 05 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046275
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
